SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Krishna Institute of Medical shines on entering into agreement with Andhra Mahila Sabha

22 Dec 2025 Evaluate

Krishna Institute of Medical Sciences is currently trading at Rs. 653.90, up by 14.30 points or 2.24% from its previous closing of Rs. 639.60 on the BSE.

The scrip opened at Rs. 657.65 and has touched a high and low of Rs. 662.65 and Rs. 645.40 respectively. So far 17160 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 798.00 on 24-Jul-2025 and a 52 week low of Rs. 474.55 on 03-Mar-2025.

Last one week high and low of the scrip stood at Rs. 674.10 and Rs. 632.05 respectively. The current market cap of the company is Rs. 26181.09 crore.

The promoters holding in the company stood at 34.11%, while Institutions and Non-Institutions held 47.15% and 18.74% respectively.

Krishna Institute of Medical Sciences has entered into a Leave and License Agreement with Andhra Mahila Sabha for taking land admeasuring approximately 1.168 acres (equivalent to 21.19 Grounds) located at Chennai, Tamil Nadu on a long term lease for setting up a Super Speciality Hospital. The investment in the project is expected to be around Rs 300 crore. 

This proposed capacity expansion represents a significant strategic milestone, establishing the company’s maiden presence in Tamil Nadu and is expected to drive improved operational performance and sustainable long-term financial returns. 

Krishna Institute of Medical Sciences is one of the largest corporate healthcare groups in AP and Telangana in terms of number of patients treated and treatments offered.


Krishna Inst.Medi Share Price

777.05 5.70 (0.74%)
16-Jun-2026 15:27 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: